赛默飞世尔科技推出Orbitrap Exploris EFOX质谱检测器 - 食品工程杂志
Thermo Fisher Scientific Debuts Orbitrap Exploris EFOX Mass Detector - Food Engineering Mag
#Fisher Scientific#Scientific Debuts#Debuts Orbitrap#Orbitrap Exploris#Exploris EFOX
生命科学资讯
生物技术与制药领域的最新动态
Thermo Fisher宣布50亿美元股票回购计划，股息政策保持不变 - 雅虎财经
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact - Yahoo Finance
#Billion Buyback#Fisher Unveils#Dividend Intact#Yahoo Finance#Thermo Fisher
10X Genomics第三季度业绩超预期，亏损收窄——Finimize报道
10X Genomics Tops Q3 Estimates And Cuts Losses - Finimize
#Genomics Tops#Cuts Losses#Losses Finimize#Genomics#Tops
10x Genomics（纳斯达克代码：TXG）第三季度业绩亮眼：销售额强劲，股价飙升13.1% - 市场财经资讯
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Markets Financial Content
#Strong Sales#Stock Jumps#Markets Financial#Financial Content#NASDAQ
10x Genomics公布2025年第三季度财务业绩 - Barchart.com
10x Genomics Reports Third Quarter 2025 Financial Results - Barchart.com
#Genomics Reports#Financial Results#Results Barchart.com#Genomics#Quarter
10x Genomics公布2025年第三季度财务业绩 - 东方进展
10x Genomics Reports Third Quarter 2025 Financial Results - Eastern Progress
#Genomics Reports#Financial Results#Eastern Progress#Results Eastern#Genomics
靶向蛋白质降解：化学蛋白质组学与诱导邻近性如何重塑药物研发
Targeted Protein Degradation: How Chemoproteomics and Induced Proximity Are Shaping Drug Discovery
#Induced Proximity#Protein Degradation#Drug Discovery#Proximity Symposium#TPD
Thermo Fisher Scientific股价为何飙升40%？——Trefis解析
Why Thermo Fisher Scientific Stock Jumped 40%? - Trefis
#Stock Jumped#Thermo Fisher#Fisher Scientific#Scientific Stock#Jumped
赛默飞世尔科技授权50亿美元股票回购计划——商业通讯
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases - Business Wire
10x Genomics (TXG)公布第三季度亏损，但营收超预期 - 纳斯达克
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq
#Beats Revenue#Revenue Estimates#Estimates Nasdaq#Genomics#TXG
10X Genomics每股收益超预期0.07美元，营收超出预估——Investing.com
10X Genomics earnings beat by $0.07, revenue topped estimates - Investing.com
#Genomics earnings#revenue topped#earnings beat#estimates Investing.com#topped estimates
与预期相比，10x Genomics (TXG) 第三季度财报关键指标分析 - 纳斯达克
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Nasdaq
#Key Metrics#Metrics Nasdaq#Genomics#TXG#Earnings
10x Genomics（纳斯达克代码：TXG）业绩公布后，预计第四季度营收为1.54亿至1.58亿美元——Stock Titan
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results - Stock Titan
#Stock Titan#guides fourth‑quarter#fourth‑quarter revenue#Genomics#NASDAQ
与预期相比：10x Genomics (TXG)第三季度财报关键指标一览 - 雅虎财经
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
#Key Metrics#Yahoo Finance#Metrics Yahoo#Genomics#TXG
10x Genomics (TXG) 公布第三季度亏损，但营收超预期 - 雅虎财经
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
#Beats Revenue#Yahoo Finance#Revenue Estimates#Estimates Yahoo#Genomics
10x Genomics（纳斯达克代码：TXG）第三季度业绩：销售强劲，股价飙升13.1% - 雅虎财经报道
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Yahoo Finance
#Strong Sales#Stock Jumps#Yahoo Finance#NASDAQ#TXG
10x Genomics公布2025年第三季度财务业绩 - 美国商业资讯
10x Genomics Reports Third Quarter 2025 Financial Results - PR Newswire
#Genomics Reports#Financial Results#Genomics#Quarter#Financial
利用龙沙先进技术解决配方难题——营养保健品商业评论
Solving formulation challenges with Lonza’s advanced technologies - Nutraceutical Business Review
#Nutraceutical Business#Business Review#Solving formulation#formulation challenges#Review Solving
Cytiva推出Fibro dT平台 - 制药合同生产领域新动态
Cytiva Launches Fibro dT Platform - Contract Pharma
#Launches Fibro#Contract Pharma#Cytiva Launches#Platform Contract#Pharma Cytiva
中国将解除对Illumina基因测序仪长达8个月的进口禁令 - 圣地亚哥时报
China to lift 8-month ban on imports of Illumina’s gene sequencers - Times of San Diego
#San Diego#Diego China#gene sequencers#sequencers Times#Illumina